Rigel Pharmaceuticals regains rights as Lilly terminates license deal
Go back to Rigel Pharmaceuticals regains rights as Lilly terminates license deal| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1108.55 +9.98 (0.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1112.24 | 52 Week Low | $67.88 | |||
| Day High | $1119.45 | P/E | 256.61 | |||
| Day Low | $1093.15 | EPS | $4.32 | |||
| Volume | 1,346,188 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 35.99 +3.08 (9.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.91 | 52 Week High | $4.38 | |||
| Open | $33.65 | 52 Week Low | $1.88 | |||
| Day High | $36.10 | P/E | N/A | |||
| Day Low | $33.64 | EPS | $-1.12 | |||
| Volume | 252,910 | |||||
